Selected research
Market Outlook & Growth Opportunities
Global Legionella Pneumophila Kits Market Outlook and Growth Opportunities 2026
Market perspective
The global Legionella Pneumophila Kits market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Legionella Pneumophila Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Legionella Pneumophila Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Legionella Pneumophila Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Legionella Pneumophila Kits market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Legionella Pneumophila Kits market include Abbott, Thermo Fisher Scientific, Vivantis, Takara Bio, Quidel Corporation, QIAGEN, Promega, Pro-Lab Diagnostics and Pall Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Legionella Pneumophila Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Legionella Pneumophila Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Legionella Pneumophila Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Legionella Pneumophila Kits market size, projected growth trends, production technologies, key applications, and end-use industries.
Legionella Pneumophila Kits Segment by Company
Abbott
Thermo Fisher Scientific
Vivantis
Takara Bio
Quidel Corporation
QIAGEN
Promega
Pro-Lab Diagnostics
Pall Corporation
IDEXX Laboratories
Hydrosense
Hologic
GeneProof
GeneoDx
Environmental Safety Technologies
DTK Water
Diatheva
Bio-Rad Laboratories
Bioneer Corporation
Accepta
Legionella Pneumophila Kits Segment by Type
Water Testing
IVD Testing
Legionella Pneumophila Kits Segment by Application
Diagnostic Labs
Water Treatment Industrial
Other
Legionella Pneumophila Kits Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Legionella Pneumophila Kits status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Legionella Pneumophila Kits market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Legionella Pneumophila Kits significant trends, drivers, influence factors in global and regions.
6. To analyze Legionella Pneumophila Kits competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Legionella Pneumophila Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Legionella Pneumophila Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Legionella Pneumophila Kits.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Legionella Pneumophila Kits market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Legionella Pneumophila Kits industry.
Chapter 3: Detailed analysis of Legionella Pneumophila Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Legionella Pneumophila Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Legionella Pneumophila Kits in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Water Testing
- IVD Testing
Applications
- Diagnostic Labs
- Water Treatment Industrial
- Other
Companies covered
- Abbott
- Thermo Fisher Scientific
- Vivantis
- Takara Bio
- Quidel Corporation
- QIAGEN
- Promega
- Pro-Lab Diagnostics
- Pall Corporation
- IDEXX Laboratories
- Hydrosense
- Hologic
- GeneProof
- GeneoDx
- Environmental Safety Technologies
- DTK Water
- Diatheva
- Bio-Rad Laboratories
- Bioneer Corporation
- Accepta
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Legionella Pneumophila Kits Sales Value (2021-2032)
- 1.2.2 Global Legionella Pneumophila Kits Sales Volume (2021-2032)
- 1.2.3 Global Legionella Pneumophila Kits Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Legionella Pneumophila Kits Market Dynamics
- 2.1 Legionella Pneumophila Kits Industry Trends
- 2.2 Legionella Pneumophila Kits Industry Drivers
- 2.3 Legionella Pneumophila Kits Industry Opportunities and Challenges
- 2.4 Legionella Pneumophila Kits Industry Restraints
3 Legionella Pneumophila Kits Market by Company
- 3.1 Global Legionella Pneumophila Kits Company Revenue Ranking in 2025
- 3.2 Global Legionella Pneumophila Kits Revenue by Company (2021-2026)
- 3.3 Global Legionella Pneumophila Kits Sales Volume by Company (2021-2026)
- 3.4 Global Legionella Pneumophila Kits Average Price by Company (2021-2026)
- 3.5 Global Legionella Pneumophila Kits Company Ranking (2024-2026)
- 3.6 Global Legionella Pneumophila Kits Company Manufacturing Base and Headquarters
- 3.7 Global Legionella Pneumophila Kits Company Product Type and Application
- 3.8 Global Legionella Pneumophila Kits Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Legionella Pneumophila Kits Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Legionella Pneumophila Kits Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Legionella Pneumophila Kits Market by Type
- 4.1 Legionella Pneumophila Kits Type Introduction
- 4.1.1 Water Testing
- 4.1.2 IVD Testing
- 4.2 Global Legionella Pneumophila Kits Sales Volume by Type
- 4.2.1 Global Legionella Pneumophila Kits Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Legionella Pneumophila Kits Sales Volume by Type (2021-2032)
- 4.2.3 Global Legionella Pneumophila Kits Sales Volume Share by Type (2021-2032)
- 4.3 Global Legionella Pneumophila Kits Sales Value by Type
- 4.3.1 Global Legionella Pneumophila Kits Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Legionella Pneumophila Kits Sales Value by Type (2021-2032)
- 4.3.3 Global Legionella Pneumophila Kits Sales Value Share by Type (2021-2032)
5 Legionella Pneumophila Kits Market by Application
- 5.1 Legionella Pneumophila Kits Application Introduction
- 5.1.1 Diagnostic Labs
- 5.1.2 Water Treatment Industrial
- 5.1.3 Other
- 5.2 Global Legionella Pneumophila Kits Sales Volume by Application
- 5.2.1 Global Legionella Pneumophila Kits Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Legionella Pneumophila Kits Sales Volume by Application (2021-2032)
- 5.2.3 Global Legionella Pneumophila Kits Sales Volume Share by Application (2021-2032)
- 5.3 Global Legionella Pneumophila Kits Sales Value by Application
- 5.3.1 Global Legionella Pneumophila Kits Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Legionella Pneumophila Kits Sales Value by Application (2021-2032)
- 5.3.3 Global Legionella Pneumophila Kits Sales Value Share by Application (2021-2032)
6 Legionella Pneumophila Kits Regional Sales and Value Analysis
- 6.1 Global Legionella Pneumophila Kits Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Legionella Pneumophila Kits Sales by Region (2021-2032)
- 6.2.1 Global Legionella Pneumophila Kits Sales by Region: 2021-2026
- 6.2.2 Global Legionella Pneumophila Kits Sales by Region (2027-2032)
- 6.3 Global Legionella Pneumophila Kits Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Legionella Pneumophila Kits Sales Value by Region (2021-2032)
- 6.4.1 Global Legionella Pneumophila Kits Sales Value by Region: 2021-2026
- 6.4.2 Global Legionella Pneumophila Kits Sales Value by Region (2027-2032)
- 6.5 Global Legionella Pneumophila Kits Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Legionella Pneumophila Kits Sales Value (2021-2032)
- 6.6.2 North America Legionella Pneumophila Kits Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Legionella Pneumophila Kits Sales Value (2021-2032)
- 6.7.2 Europe Legionella Pneumophila Kits Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Legionella Pneumophila Kits Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Legionella Pneumophila Kits Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Legionella Pneumophila Kits Sales Value (2021-2032)
- 6.9.2 South America Legionella Pneumophila Kits Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Legionella Pneumophila Kits Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Legionella Pneumophila Kits Sales Value Share by Country, 2025 VS 2032
7 Legionella Pneumophila Kits Country-level Sales and Value Analysis
- 7.1 Global Legionella Pneumophila Kits Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Legionella Pneumophila Kits Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Legionella Pneumophila Kits Sales by Country (2021-2032)
- 7.3.1 Global Legionella Pneumophila Kits Sales by Country (2021-2026)
- 7.3.2 Global Legionella Pneumophila Kits Sales by Country (2027-2032)
- 7.4 Global Legionella Pneumophila Kits Sales Value by Country (2021-2032)
- 7.4.1 Global Legionella Pneumophila Kits Sales Value by Country (2021-2026)
- 7.4.2 Global Legionella Pneumophila Kits Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.9.2 France Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.16.2 China Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.19.2 India Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Legionella Pneumophila Kits Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Legionella Pneumophila Kits Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Legionella Pneumophila Kits Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Abbott
- 8.1.1 Abbott Company Information
- 8.1.2 Abbott Business Overview
- 8.1.3 Abbott Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Abbott Legionella Pneumophila Kits Product Portfolio
- 8.1.5 Abbott Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Legionella Pneumophila Kits Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 Vivantis
- 8.3.1 Vivantis Company Information
- 8.3.2 Vivantis Business Overview
- 8.3.3 Vivantis Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Vivantis Legionella Pneumophila Kits Product Portfolio
- 8.3.5 Vivantis Recent Developments
- 8.4 Takara Bio
- 8.4.1 Takara Bio Company Information
- 8.4.2 Takara Bio Business Overview
- 8.4.3 Takara Bio Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Takara Bio Legionella Pneumophila Kits Product Portfolio
- 8.4.5 Takara Bio Recent Developments
- 8.5 Quidel Corporation
- 8.5.1 Quidel Corporation Company Information
- 8.5.2 Quidel Corporation Business Overview
- 8.5.3 Quidel Corporation Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Quidel Corporation Legionella Pneumophila Kits Product Portfolio
- 8.5.5 Quidel Corporation Recent Developments
- 8.6 QIAGEN
- 8.6.1 QIAGEN Company Information
- 8.6.2 QIAGEN Business Overview
- 8.6.3 QIAGEN Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.6.4 QIAGEN Legionella Pneumophila Kits Product Portfolio
- 8.6.5 QIAGEN Recent Developments
- 8.7 Promega
- 8.7.1 Promega Company Information
- 8.7.2 Promega Business Overview
- 8.7.3 Promega Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Promega Legionella Pneumophila Kits Product Portfolio
- 8.7.5 Promega Recent Developments
- 8.8 Pro-Lab Diagnostics
- 8.8.1 Pro-Lab Diagnostics Company Information
- 8.8.2 Pro-Lab Diagnostics Business Overview
- 8.8.3 Pro-Lab Diagnostics Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Pro-Lab Diagnostics Legionella Pneumophila Kits Product Portfolio
- 8.8.5 Pro-Lab Diagnostics Recent Developments
- 8.9 Pall Corporation
- 8.9.1 Pall Corporation Company Information
- 8.9.2 Pall Corporation Business Overview
- 8.9.3 Pall Corporation Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Pall Corporation Legionella Pneumophila Kits Product Portfolio
- 8.9.5 Pall Corporation Recent Developments
- 8.10 IDEXX Laboratories
- 8.10.1 IDEXX Laboratories Company Information
- 8.10.2 IDEXX Laboratories Business Overview
- 8.10.3 IDEXX Laboratories Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.10.4 IDEXX Laboratories Legionella Pneumophila Kits Product Portfolio
- 8.10.5 IDEXX Laboratories Recent Developments
- 8.11 Hydrosense
- 8.11.1 Hydrosense Company Information
- 8.11.2 Hydrosense Business Overview
- 8.11.3 Hydrosense Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Hydrosense Legionella Pneumophila Kits Product Portfolio
- 8.11.5 Hydrosense Recent Developments
- 8.12 Hologic
- 8.12.1 Hologic Company Information
- 8.12.2 Hologic Business Overview
- 8.12.3 Hologic Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Hologic Legionella Pneumophila Kits Product Portfolio
- 8.12.5 Hologic Recent Developments
- 8.13 GeneProof
- 8.13.1 GeneProof Company Information
- 8.13.2 GeneProof Business Overview
- 8.13.3 GeneProof Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.13.4 GeneProof Legionella Pneumophila Kits Product Portfolio
- 8.13.5 GeneProof Recent Developments
- 8.14 GeneoDx
- 8.14.1 GeneoDx Company Information
- 8.14.2 GeneoDx Business Overview
- 8.14.3 GeneoDx Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.14.4 GeneoDx Legionella Pneumophila Kits Product Portfolio
- 8.14.5 GeneoDx Recent Developments
- 8.15 Environmental Safety Technologies
- 8.15.1 Environmental Safety Technologies Company Information
- 8.15.2 Environmental Safety Technologies Business Overview
- 8.15.3 Environmental Safety Technologies Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Environmental Safety Technologies Legionella Pneumophila Kits Product Portfolio
- 8.15.5 Environmental Safety Technologies Recent Developments
- 8.16 DTK Water
- 8.16.1 DTK Water Company Information
- 8.16.2 DTK Water Business Overview
- 8.16.3 DTK Water Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.16.4 DTK Water Legionella Pneumophila Kits Product Portfolio
- 8.16.5 DTK Water Recent Developments
- 8.17 Diatheva
- 8.17.1 Diatheva Company Information
- 8.17.2 Diatheva Business Overview
- 8.17.3 Diatheva Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Diatheva Legionella Pneumophila Kits Product Portfolio
- 8.17.5 Diatheva Recent Developments
- 8.18 Bio-Rad Laboratories
- 8.18.1 Bio-Rad Laboratories Company Information
- 8.18.2 Bio-Rad Laboratories Business Overview
- 8.18.3 Bio-Rad Laboratories Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Bio-Rad Laboratories Legionella Pneumophila Kits Product Portfolio
- 8.18.5 Bio-Rad Laboratories Recent Developments
- 8.19 Bioneer Corporation
- 8.19.1 Bioneer Corporation Company Information
- 8.19.2 Bioneer Corporation Business Overview
- 8.19.3 Bioneer Corporation Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Bioneer Corporation Legionella Pneumophila Kits Product Portfolio
- 8.19.5 Bioneer Corporation Recent Developments
- 8.20 Accepta
- 8.20.1 Accepta Company Information
- 8.20.2 Accepta Business Overview
- 8.20.3 Accepta Legionella Pneumophila Kits Sales, Value and Gross Margin (2021-2026)
- 8.20.4 Accepta Legionella Pneumophila Kits Product Portfolio
- 8.20.5 Accepta Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Legionella Pneumophila Kits Value Chain Analysis
- 9.1.1 Legionella Pneumophila Kits Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Legionella Pneumophila Kits Sales Mode & Process
- 9.2 Legionella Pneumophila Kits Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Legionella Pneumophila Kits Distributors
- 9.2.3 Legionella Pneumophila Kits Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst